Global Neuromodulation Devices Market Size study, by Product (Spinal Cord Stimulators, Deep Brain Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators, Transcranial Magnetic Stimulators, Others), by Technology (Internal, External) by Application (Parkinson’s Disease, Chronic Pain, Migraine, Epilepsy, Tremor, Depression, Urinary & Faecal Incontinence, Others) by Biomaterial (Polymeric Biomaterial, Metallic Biomaterial, Ceramic Biomaterial) by End-use (Hospitals & Ambulatory Surgery Centers (ASC), Clinics & Physiotherapy Centers, Others) and Regional Forecasts 2022-2028
Global Neuromodulation Devices Market is valued approximately USD 3.19 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 9.5% over the forecast period 2022-2028. Parkinson's disease, cerebrovascular illnesses, Alzheimer's disease, stroke, and tremors are all neurological disorders that impact the body's peripheral nervous system and central nervous system, and neuromodulation treatment is an effective technique to control these diseases. Neuromodulation is a minimally invasive or non-invasive therapy used to treat patients with neurological problems, and neuromodulation devices are implanted medical devices that employ electrical stimulation to change a specific neuron. According to the American Academy of Neurology, almost 1 million people in the United States are affected with Parkinson's disease, with 60,000 new cases diagnosed each year. Furthermore, according to the Hearing Health Foundation in 2020, 48 million individuals in the United States and 477 million globally have deafness and tinnitus. Also, according to the World Health Organization factsheet, almost 50 million people worldwide suffer with epilepsy, with around 2.4 million instances diagnosed each year. As a result of the rising prevalence of neurological illnesses, demand for neuromodulation devices is likely to rise throughout the forecast period. However, the negative consequences of implantation of a neuromodulation device into the body, such as allergic response and prickling and tingling of the skin, hinder market expansion during the projection period of 2022-2028.
The key regions considered for the Global Neuromodulation Devices Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America has the market's highest revenue share. The growing number of patients suffering from neurological disorders, which increases the demand for neuromodulation devices, increased competition among market players, and significant investment in research and development to produce novel therapeutic solutions are all contributing to market growth in North America. Asia Pacific is predicted to grow at the quickest rate throughout the projection period because of the increased prevalence of neurological illnesses, quickly developing healthcare infrastructure, growing government support, and an increasing number of startups in this area,
Major market player included in this report are:
Boston Scientific Corporation
Abbott
NEVRO CORP.
Neuronetics
Medtronic
LivaNova
Synapse Biomedical, Inc.
NeuroSigma
NeuroPace
BioControl Medical
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product Type:
Spinal Cord Stimulators
Deep Brain Stimulators
Sacral Nerve Stimulators
Vagus Nerve Stimulators
Transcranial Magnetic Stimulators
Others
By Technology;
Internal
External
By Application:
Parkinson’s Disease
Chronic Pain
Migraine
Epilepsy
Tremor
Depression
Urinary & Faecal Incontinence
Others
By Biomaterial:
Polymeric Biomaterial
Metallic Biomaterial
Ceramic Biomaterial
By End-use:
Hospitals & Ambulatory Surgery Centers (ASC)
Clinics & Physiotherapy Centers
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028
Target Audience of the Global Neuromodulation Devices Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
The key regions considered for the Global Neuromodulation Devices Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America has the market's highest revenue share. The growing number of patients suffering from neurological disorders, which increases the demand for neuromodulation devices, increased competition among market players, and significant investment in research and development to produce novel therapeutic solutions are all contributing to market growth in North America. Asia Pacific is predicted to grow at the quickest rate throughout the projection period because of the increased prevalence of neurological illnesses, quickly developing healthcare infrastructure, growing government support, and an increasing number of startups in this area,
Major market player included in this report are:
Boston Scientific Corporation
Abbott
NEVRO CORP.
Neuronetics
Medtronic
LivaNova
Synapse Biomedical, Inc.
NeuroSigma
NeuroPace
BioControl Medical
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product Type:
Spinal Cord Stimulators
Deep Brain Stimulators
Sacral Nerve Stimulators
Vagus Nerve Stimulators
Transcranial Magnetic Stimulators
Others
By Technology;
Internal
External
By Application:
Parkinson’s Disease
Chronic Pain
Migraine
Epilepsy
Tremor
Depression
Urinary & Faecal Incontinence
Others
By Biomaterial:
Polymeric Biomaterial
Metallic Biomaterial
Ceramic Biomaterial
By End-use:
Hospitals & Ambulatory Surgery Centers (ASC)
Clinics & Physiotherapy Centers
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028
Target Audience of the Global Neuromodulation Devices Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
1.2.1. Neuromodulation Devices Market, by Region, 2020-2028 (USD Billion)
1.2.2. Neuromodulation Devices Market, by Product, 2020-2028 (USD Billion)
1.2.3. Neuromodulation Devices Market, by Technology, 2020-2028 (USD Billion)
1.2.4. Neuromodulation Devices Market, by Application, 2020-2028 (USD Billion)
1.2.5. Neuromodulation Devices Market, by Biomaterial, 2020-2028 (USD Billion)
1.2.6. Neuromodulation Devices Market, by End-Use, 2020-2028 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL NEUROMODULATION DEVICES MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL NEUROMODULATION DEVICES MARKET DYNAMICS
3.1. Neuromodulation Devices Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Increasing cases of Neurological Diseases.
3.1.1.2. Increasing Research and Development in Devices
3.1.2. Market Challenges
3.1.2.1. Negative effects such as anaphylactic reaction and prickling and tingling of the skin
3.1.3. Market Opportunities
3.1.3.1. Demand for Minimally Invasive Surgeries
CHAPTER 4. GLOBAL NEUROMODULATION DEVICES MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
CHAPTER 5. RISK ASSESSMENT: COVID-19 IMPACT
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 Market scenario
CHAPTER 6. GLOBAL NEUROMODULATION DEVICES MARKET, BY PRODUCT
6.1. Market Snapshot
6.2. Global Neuromodulation Devices Market by Product, Performance - Potential Analysis
6.3. Global Neuromodulation Devices Market Estimates & Forecasts by Product 2018-2028 (USD Billion)
6.4. Neuromodulation Devices Market, Sub Segment Analysis
6.4.1. Spinal Cord Stimulators
6.4.2. Deep Brain Stimulators
6.4.3. Sacral Nerve Stimulators
6.4.4. Vagus Nerve Stimulators
6.4.5. Transcranial Magnetic Stimulators
6.4.6. Others
CHAPTER 7. GLOBAL NEUROMODULATION DEVICES MARKET, BY TECHNOLOGY
7.1. Market Snapshot
7.2. Global Neuromodulation Devices Market by Technology, Performance - Potential Analysis
7.3. Global Neuromodulation Devices Market Estimates & Forecasts by Technology 2018-2028 (USD Billion)
7.4. Neuromodulation Devices Market, Sub Segment Analysis
7.4.1. Internal
7.4.2. External
CHAPTER 8. GLOBAL NEUROMODULATION DEVICES MARKET, BY APPLICATION
8.1. Market Snapshot
8.2. Global Neuromodulation Devices Market by Application, Performance - Potential Analysis
8.3. Global Neuromodulation Devices Market Estimates & Forecasts by Application 2018-2028 (USD Billion)
8.4. Neuromodulation Devices Market, Sub Segment Analysis
8.4.1. Parkinson’s Disease
8.4.2. Chronic Pain
8.4.3. Migraine
8.4.4. Epilepsy
8.4.5. Tremor
8.4.6. Depression
8.4.7. Urinary & Faecal Incontinence
8.4.8. Others
CHAPTER 9. GLOBAL NEUROMODULATION DEVICES MARKET, BY BIOMATERIAL
9.1. Market Snapshot
9.2. Global Neuromodulation Devices Market by Biomaterial, Performance - Potential Analysis
9.3. Global Neuromodulation Devices Market Estimates & Forecasts by Biomaterial 2018-2028 (USD Billion)
9.4. Neuromodulation Devices Market, Sub Segment Analysis
9.4.1. Polymeric Biomaterial
9.4.2. Metallic Biomaterial
9.4.3. Ceramic Biomaterial
CHAPTER 10. GLOBAL NEUROMODULATION DEVICES MARKET, BY END-USER
10.1. Market Snapshot
10.2. Global Neuromodulation Devices Market by End-user, Performance - Potential Analysis
10.3. Global Neuromodulation Devices Market Estimates & Forecasts by End-user 2018-2028 (USD Billion)
10.4. Neuromodulation Devices Market, Sub Segment Analysis
10.4.1. Hospitals & Ambulatory Surgery Centers (ASC)
10.4.2. Clinics & Physiotherapy Centers
10.4.3. Others
CHAPTER 11. GLOBAL NEUROMODULATION DEVICES MARKET, REGIONAL ANALYSIS
11.1. Neuromodulation Devices Market, Regional Market Snapshot
11.2. North America Neuromodulation Devices Market
11.2.1. U.S. Neuromodulation Devices Market
11.2.1.1. Product breakdown estimates & forecasts, 2018-2028
11.2.1.2. Technology breakdown estimates & forecasts, 2018-2028
11.2.1.3. Application breakdown estimates & forecasts, 2018-2028
11.2.1.4. Biomaterial breakdown estimates & forecasts, 2018-2028
11.2.1.5. End user breakdown estimates & forecasts, 2018-2028
11.2.2. Canada Neuromodulation Devices Market
11.3. Europe Neuromodulation Devices Market Snapshot
11.3.1. U.K. Neuromodulation Devices Market
11.3.2. Germany Neuromodulation Devices Market
11.3.3. France Neuromodulation Devices Market
11.3.4. Spain Neuromodulation Devices Market
11.3.5. Italy Neuromodulation Devices Market
11.3.6. Rest of Europe Neuromodulation Devices Market
11.4. Asia-Pacific Neuromodulation Devices Market Snapshot
11.4.1. China Neuromodulation Devices Market
11.4.2. India Neuromodulation Devices Market
11.4.3. Japan Neuromodulation Devices Market
11.4.4. Australia Neuromodulation Devices Market
11.4.5. South Korea Neuromodulation Devices Market
11.4.6. Rest of Asia Pacific Neuromodulation Devices Market
11.5. Latin America Neuromodulation Devices Market Snapshot
11.5.1. Brazil Neuromodulation Devices Market
11.5.2. Mexico Neuromodulation Devices Market
11.6. Rest of The World Neuromodulation Devices Market
CHAPTER 12. COMPETITIVE INTELLIGENCE
12.1. Top Market Strategies
12.2. Company Profiles
12.2.1. Boston Scientific Corporation
12.2.1.1. Key Information
12.2.1.2. Overview
12.2.1.3. Financial (Subject to Data Availability)
12.2.1.4. Product Summary
12.2.1.5. Recent Developments
12.2.2. Abbott
12.2.3. NEVRO CORP.
12.2.4. Neuronetics
12.2.5. Medtronic
12.2.6. LivaNova
12.2.7. Synapse Biomedical, Inc.
12.2.8. NeuroSigma
12.2.9. NeuroPace
12.2.10. BioControl Medical
CHAPTER 13. RESEARCH PROCESS
13.1. Research Process
13.1.1. Data Mining
13.1.2. Analysis
13.1.3. Market Estimation
13.1.4. Validation
13.1.5. Publishing
13.2. Research Attributes
13.3. Research Assumption
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
1.2.1. Neuromodulation Devices Market, by Region, 2020-2028 (USD Billion)
1.2.2. Neuromodulation Devices Market, by Product, 2020-2028 (USD Billion)
1.2.3. Neuromodulation Devices Market, by Technology, 2020-2028 (USD Billion)
1.2.4. Neuromodulation Devices Market, by Application, 2020-2028 (USD Billion)
1.2.5. Neuromodulation Devices Market, by Biomaterial, 2020-2028 (USD Billion)
1.2.6. Neuromodulation Devices Market, by End-Use, 2020-2028 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL NEUROMODULATION DEVICES MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL NEUROMODULATION DEVICES MARKET DYNAMICS
3.1. Neuromodulation Devices Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Increasing cases of Neurological Diseases.
3.1.1.2. Increasing Research and Development in Devices
3.1.2. Market Challenges
3.1.2.1. Negative effects such as anaphylactic reaction and prickling and tingling of the skin
3.1.3. Market Opportunities
3.1.3.1. Demand for Minimally Invasive Surgeries
CHAPTER 4. GLOBAL NEUROMODULATION DEVICES MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
CHAPTER 5. RISK ASSESSMENT: COVID-19 IMPACT
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 Market scenario
CHAPTER 6. GLOBAL NEUROMODULATION DEVICES MARKET, BY PRODUCT
6.1. Market Snapshot
6.2. Global Neuromodulation Devices Market by Product, Performance - Potential Analysis
6.3. Global Neuromodulation Devices Market Estimates & Forecasts by Product 2018-2028 (USD Billion)
6.4. Neuromodulation Devices Market, Sub Segment Analysis
6.4.1. Spinal Cord Stimulators
6.4.2. Deep Brain Stimulators
6.4.3. Sacral Nerve Stimulators
6.4.4. Vagus Nerve Stimulators
6.4.5. Transcranial Magnetic Stimulators
6.4.6. Others
CHAPTER 7. GLOBAL NEUROMODULATION DEVICES MARKET, BY TECHNOLOGY
7.1. Market Snapshot
7.2. Global Neuromodulation Devices Market by Technology, Performance - Potential Analysis
7.3. Global Neuromodulation Devices Market Estimates & Forecasts by Technology 2018-2028 (USD Billion)
7.4. Neuromodulation Devices Market, Sub Segment Analysis
7.4.1. Internal
7.4.2. External
CHAPTER 8. GLOBAL NEUROMODULATION DEVICES MARKET, BY APPLICATION
8.1. Market Snapshot
8.2. Global Neuromodulation Devices Market by Application, Performance - Potential Analysis
8.3. Global Neuromodulation Devices Market Estimates & Forecasts by Application 2018-2028 (USD Billion)
8.4. Neuromodulation Devices Market, Sub Segment Analysis
8.4.1. Parkinson’s Disease
8.4.2. Chronic Pain
8.4.3. Migraine
8.4.4. Epilepsy
8.4.5. Tremor
8.4.6. Depression
8.4.7. Urinary & Faecal Incontinence
8.4.8. Others
CHAPTER 9. GLOBAL NEUROMODULATION DEVICES MARKET, BY BIOMATERIAL
9.1. Market Snapshot
9.2. Global Neuromodulation Devices Market by Biomaterial, Performance - Potential Analysis
9.3. Global Neuromodulation Devices Market Estimates & Forecasts by Biomaterial 2018-2028 (USD Billion)
9.4. Neuromodulation Devices Market, Sub Segment Analysis
9.4.1. Polymeric Biomaterial
9.4.2. Metallic Biomaterial
9.4.3. Ceramic Biomaterial
CHAPTER 10. GLOBAL NEUROMODULATION DEVICES MARKET, BY END-USER
10.1. Market Snapshot
10.2. Global Neuromodulation Devices Market by End-user, Performance - Potential Analysis
10.3. Global Neuromodulation Devices Market Estimates & Forecasts by End-user 2018-2028 (USD Billion)
10.4. Neuromodulation Devices Market, Sub Segment Analysis
10.4.1. Hospitals & Ambulatory Surgery Centers (ASC)
10.4.2. Clinics & Physiotherapy Centers
10.4.3. Others
CHAPTER 11. GLOBAL NEUROMODULATION DEVICES MARKET, REGIONAL ANALYSIS
11.1. Neuromodulation Devices Market, Regional Market Snapshot
11.2. North America Neuromodulation Devices Market
11.2.1. U.S. Neuromodulation Devices Market
11.2.1.1. Product breakdown estimates & forecasts, 2018-2028
11.2.1.2. Technology breakdown estimates & forecasts, 2018-2028
11.2.1.3. Application breakdown estimates & forecasts, 2018-2028
11.2.1.4. Biomaterial breakdown estimates & forecasts, 2018-2028
11.2.1.5. End user breakdown estimates & forecasts, 2018-2028
11.2.2. Canada Neuromodulation Devices Market
11.3. Europe Neuromodulation Devices Market Snapshot
11.3.1. U.K. Neuromodulation Devices Market
11.3.2. Germany Neuromodulation Devices Market
11.3.3. France Neuromodulation Devices Market
11.3.4. Spain Neuromodulation Devices Market
11.3.5. Italy Neuromodulation Devices Market
11.3.6. Rest of Europe Neuromodulation Devices Market
11.4. Asia-Pacific Neuromodulation Devices Market Snapshot
11.4.1. China Neuromodulation Devices Market
11.4.2. India Neuromodulation Devices Market
11.4.3. Japan Neuromodulation Devices Market
11.4.4. Australia Neuromodulation Devices Market
11.4.5. South Korea Neuromodulation Devices Market
11.4.6. Rest of Asia Pacific Neuromodulation Devices Market
11.5. Latin America Neuromodulation Devices Market Snapshot
11.5.1. Brazil Neuromodulation Devices Market
11.5.2. Mexico Neuromodulation Devices Market
11.6. Rest of The World Neuromodulation Devices Market
CHAPTER 12. COMPETITIVE INTELLIGENCE
12.1. Top Market Strategies
12.2. Company Profiles
12.2.1. Boston Scientific Corporation
12.2.1.1. Key Information
12.2.1.2. Overview
12.2.1.3. Financial (Subject to Data Availability)
12.2.1.4. Product Summary
12.2.1.5. Recent Developments
12.2.2. Abbott
12.2.3. NEVRO CORP.
12.2.4. Neuronetics
12.2.5. Medtronic
12.2.6. LivaNova
12.2.7. Synapse Biomedical, Inc.
12.2.8. NeuroSigma
12.2.9. NeuroPace
12.2.10. BioControl Medical
CHAPTER 13. RESEARCH PROCESS
13.1. Research Process
13.1.1. Data Mining
13.1.2. Analysis
13.1.3. Market Estimation
13.1.4. Validation
13.1.5. Publishing
13.2. Research Attributes
13.3. Research Assumption
LIST OF TABLES
TABLE 1. Global Neuromodulation Devices Market, report scope
TABLE 2. Global Neuromodulation Devices Market estimates & forecasts by Region 2018-2028 (USD Billion)
TABLE 3. Global Neuromodulation Devices Market estimates & forecasts by Product 2018-2028 (USD Billion)
TABLE 4. Global Neuromodulation Devices Market estimates & forecasts by Technology 2018-2028 (USD Billion)
TABLE 5. Global Neuromodulation Devices Market estimates & forecasts by Application 2018-2028 (USD Billion)
TABLE 6. Global Neuromodulation Devices Market estimates & forecasts by Biomaterial 2018-2028 (USD Billion)
TABLE 7. Global Neuromodulation Devices Market estimates & forecasts by End-user 2018-2028 (USD Billion)
TABLE 8. Global Neuromodulation Devices Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 9. Global Neuromodulation Devices Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 10. Global Neuromodulation Devices Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 11. Global Neuromodulation Devices Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 12. Global Neuromodulation Devices Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 13. Global Neuromodulation Devices Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 14. Global Neuromodulation Devices Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 15. Global Neuromodulation Devices Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 16. Global Neuromodulation Devices Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 17. Global Neuromodulation Devices Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 18. U.S. Neuromodulation Devices Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 19. U.S. Neuromodulation Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 20. U.S. Neuromodulation Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 21. Canada Neuromodulation Devices Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 22. Canada Neuromodulation Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 23. Canada Neuromodulation Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 24. UK Neuromodulation Devices Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 25. UK Neuromodulation Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 26. UK Neuromodulation Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 27. Germany Neuromodulation Devices Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 28. Germany Neuromodulation Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 29. Germany Neuromodulation Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 30. RoE Neuromodulation Devices Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 31. RoE Neuromodulation Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 32. RoE Neuromodulation Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 33. China Neuromodulation Devices Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 34. China Neuromodulation Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 35. China Neuromodulation Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 36. India Neuromodulation Devices Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 37. India Neuromodulation Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 38. India Neuromodulation Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 39. Japan Neuromodulation Devices Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 40. Japan Neuromodulation Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 41. Japan Neuromodulation Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 42. RoAPAC Neuromodulation Devices Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 43. RoAPAC Neuromodulation Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 44. RoAPAC Neuromodulation Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 45. Brazil Neuromodulation Devices Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 46. Brazil Neuromodulation Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 47. Brazil Neuromodulation Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 48. Mexico Neuromodulation Devices Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 49. Mexico Neuromodulation Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 50. Mexico Neuromodulation Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 51. RoLA Neuromodulation Devices Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 52. RoLA Neuromodulation Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 53. RoLA Neuromodulation Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 54. Row Neuromodulation Devices Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 55. Row Neuromodulation Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 56. Row Neuromodulation Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 57. List of secondary sources, used in the study of global Neuromodulation Devices Market
TABLE 58. List of primary sources, used in the study of global Neuromodulation Devices Market
TABLE 59. Years considered for the study
TABLE 60. Exchange rates considered
TABLE 1. Global Neuromodulation Devices Market, report scope
TABLE 2. Global Neuromodulation Devices Market estimates & forecasts by Region 2018-2028 (USD Billion)
TABLE 3. Global Neuromodulation Devices Market estimates & forecasts by Product 2018-2028 (USD Billion)
TABLE 4. Global Neuromodulation Devices Market estimates & forecasts by Technology 2018-2028 (USD Billion)
TABLE 5. Global Neuromodulation Devices Market estimates & forecasts by Application 2018-2028 (USD Billion)
TABLE 6. Global Neuromodulation Devices Market estimates & forecasts by Biomaterial 2018-2028 (USD Billion)
TABLE 7. Global Neuromodulation Devices Market estimates & forecasts by End-user 2018-2028 (USD Billion)
TABLE 8. Global Neuromodulation Devices Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 9. Global Neuromodulation Devices Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 10. Global Neuromodulation Devices Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 11. Global Neuromodulation Devices Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 12. Global Neuromodulation Devices Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 13. Global Neuromodulation Devices Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 14. Global Neuromodulation Devices Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 15. Global Neuromodulation Devices Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 16. Global Neuromodulation Devices Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 17. Global Neuromodulation Devices Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 18. U.S. Neuromodulation Devices Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 19. U.S. Neuromodulation Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 20. U.S. Neuromodulation Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 21. Canada Neuromodulation Devices Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 22. Canada Neuromodulation Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 23. Canada Neuromodulation Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 24. UK Neuromodulation Devices Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 25. UK Neuromodulation Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 26. UK Neuromodulation Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 27. Germany Neuromodulation Devices Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 28. Germany Neuromodulation Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 29. Germany Neuromodulation Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 30. RoE Neuromodulation Devices Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 31. RoE Neuromodulation Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 32. RoE Neuromodulation Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 33. China Neuromodulation Devices Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 34. China Neuromodulation Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 35. China Neuromodulation Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 36. India Neuromodulation Devices Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 37. India Neuromodulation Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 38. India Neuromodulation Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 39. Japan Neuromodulation Devices Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 40. Japan Neuromodulation Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 41. Japan Neuromodulation Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 42. RoAPAC Neuromodulation Devices Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 43. RoAPAC Neuromodulation Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 44. RoAPAC Neuromodulation Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 45. Brazil Neuromodulation Devices Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 46. Brazil Neuromodulation Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 47. Brazil Neuromodulation Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 48. Mexico Neuromodulation Devices Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 49. Mexico Neuromodulation Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 50. Mexico Neuromodulation Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 51. RoLA Neuromodulation Devices Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 52. RoLA Neuromodulation Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 53. RoLA Neuromodulation Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 54. Row Neuromodulation Devices Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 55. Row Neuromodulation Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 56. Row Neuromodulation Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 57. List of secondary sources, used in the study of global Neuromodulation Devices Market
TABLE 58. List of primary sources, used in the study of global Neuromodulation Devices Market
TABLE 59. Years considered for the study
TABLE 60. Exchange rates considered
LIST OF FIGURES
FIG 1. Global Neuromodulation Devices Market, research methodology
FIG 2. Global Neuromodulation Devices Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Neuromodulation Devices Market, key trends 2021
FIG 5. Global Neuromodulation Devices Market, growth prospects 2022-2028
FIG 6. Global Neuromodulation Devices Market, porters 5 force model
FIG 7. Global Neuromodulation Devices Market, pest analysis
FIG 8. Global Neuromodulation Devices Market, value chain analysis
FIG 9. Global Neuromodulation Devices Market by segment, 2018 & 2028 (USD Billion)
FIG 10. Global Neuromodulation Devices Market by segment, 2018 & 2028 (USD Billion)
FIG 11. Global Neuromodulation Devices Market by segment, 2018 & 2028 (USD Billion)
FIG 12. Global Neuromodulation Devices Market by segment, 2018 & 2028 (USD Billion)
FIG 13. Global Neuromodulation Devices Market by segment, 2018 & 2028 (USD Billion)
FIG 14. Global Neuromodulation Devices Market, regional snapshot 2018 & 2028
FIG 15. North America Neuromodulation Devices Market 2018 & 2028 (USD Billion)
FIG 16. Europe Neuromodulation Devices Market 2018 & 2028 (USD Billion)
FIG 17. Asia pacific Neuromodulation Devices Market 2018 & 2028 (USD Billion)
FIG 18. Latin America Neuromodulation Devices Market 2018 & 2028 (USD Billion)
FIG 19. Global Neuromodulation Devices Market, company Market share analysis (2021)
FIG 1. Global Neuromodulation Devices Market, research methodology
FIG 2. Global Neuromodulation Devices Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Neuromodulation Devices Market, key trends 2021
FIG 5. Global Neuromodulation Devices Market, growth prospects 2022-2028
FIG 6. Global Neuromodulation Devices Market, porters 5 force model
FIG 7. Global Neuromodulation Devices Market, pest analysis
FIG 8. Global Neuromodulation Devices Market, value chain analysis
FIG 9. Global Neuromodulation Devices Market by segment, 2018 & 2028 (USD Billion)
FIG 10. Global Neuromodulation Devices Market by segment, 2018 & 2028 (USD Billion)
FIG 11. Global Neuromodulation Devices Market by segment, 2018 & 2028 (USD Billion)
FIG 12. Global Neuromodulation Devices Market by segment, 2018 & 2028 (USD Billion)
FIG 13. Global Neuromodulation Devices Market by segment, 2018 & 2028 (USD Billion)
FIG 14. Global Neuromodulation Devices Market, regional snapshot 2018 & 2028
FIG 15. North America Neuromodulation Devices Market 2018 & 2028 (USD Billion)
FIG 16. Europe Neuromodulation Devices Market 2018 & 2028 (USD Billion)
FIG 17. Asia pacific Neuromodulation Devices Market 2018 & 2028 (USD Billion)
FIG 18. Latin America Neuromodulation Devices Market 2018 & 2028 (USD Billion)
FIG 19. Global Neuromodulation Devices Market, company Market share analysis (2021)
